Theravance Biopharma, Inc.
NASDAQ:TBPH · NASDAQ Global Market
-$0.07 today
Vol 0.79M · Avg 0.43M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+56.86%
Period High
$20.74
Period Low
$10.57
Latest
$16.58
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Day One Biopharmaceuticals, Inc.
DAWN
$2.22B
Tyra Biosciences, Inc.
NASDAQ:TYRA
$1.67B
Vir Biotechnology, Inc.
NASDAQ:VIR
$1.53B
ArriVent BioPharma, Inc. Common Stock
NASDAQ:AVBP
$1.48B
Monte Rosa Therapeutics, Inc.
NASDAQ:GLUE
$1.19B
BlackRock Technology and Private Equity Term Trust
BTX
$1.08B
Replimune Group, Inc.
NASDAQ:REPL
$841.41M
Geron Corporation
NASDAQ:GERN
$821.15M
Valneva SE
NASDAQ:VALN
$507.30M
LENZ Therapeutics, Inc.
NASDAQ:LENZ
$184.05M
What is the latest TBPH filing?
The latest filing shown is 4 dated Jun 17, 2026.
How many recent filings does TBPH have?
Intrinsic Alpha currently shows 20 recent filings for TBPH.
Explore More
Continue the stock analysis
Jump to another research area for this company.